Concourse Financial Group Securities’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-9,678
Closed -$2.65M 88
2024
Q4
$2.65M Buy
9,678
+31
+0.3% +$9.2K 0.15% 145
2024
Q3
$3.11M Sell
9,647
-18
-0.2% -$5.89K 0.18% 125
2024
Q2
$3.02M Sell
9,665
-110
-1% -$32.3K 0.19% 119
2024
Q1
$2.78M Buy
9,775
+748
+8% +$219K 0.18% 127
2023
Q4
$2.6M Buy
9,027
+1,733
+24% +$472K 0.19% 114
2023
Q3
$1.96M Buy
7,294
+3,286
+82% +$820K 0.15% 142
2023
Q2
$890K Buy
4,008
+620
+18% +$144K 0.07% 297
2023
Q1
$819K Buy
3,388
+374
+12% +$91.8K 0.06% 308
2022
Q4
$792K Buy
+3,014
New +$808K 0.06% 309
2022
Q3
Sell
-1,951
Closed -$473K 2033
2022
Q2
$475K Sell
1,951
-75
-4% -$18.4K 0.04% 404
2022
Q1
$490K Sell
2,026
-464
-19% -$107K 0.04% 427
2021
Q4
$560K Buy
2,490
+388
+18% +$81.9K 0.03% 454
2021
Q3
$447K Buy
2,102
+291
+16% +$67K 0.03% 490
2021
Q2
$441K Buy
1,811
+356
+24% +$87.6K 0.03% 482
2021
Q1
$362K Sell
1,455
-425
-23% -$101K 0.03% 492
2020
Q4
$432K Sell
1,880
-519
-22% -$120K 0.03% 409
2020
Q3
$610K Sell
2,399
-12
-0.5% -$2.97K 0.05% 296
2020
Q2
$569K Buy
2,411
+152
+7% +$34.7K 0.06% 277
2020
Q1
$458K Buy
+2,259
New +$493K 0.05% 265
2019
Q3
Sell
-69
Closed -$13.2K 1751
2019
Q2
$13K Sell
69
-1,649
-96% -$295K ﹤0.01% 1395
2019
Q1
$326K Sell
1,718
-192
-10% -$36.7K 0.03% 353
2018
Q4
$371K Buy
1,910
+1,193
+166% +$233K 0.04% 291
2018
Q3
$149K Buy
+717
New +$141K 0.04% 337

Other funds holding AMGN

Concourse Financial Group Securities's AMGN Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of Amgen (AMGN) in Q1 2025, closing a stake of 9,678 shares — an estimated $2.65M sold.

Concourse Financial Group Securities first reported a position in AMGN in Q3 2018 and held it in 23 quarters. The position peaked at $3.11M in Q3 2024. 2,926 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 9,678 Amgen shares in Q1 2025, an estimated $2.65M.
  • Concourse Financial Group Securities first reported a position in Amgen in Q3 2018 and held it in 23 quarters.
  • Concourse Financial Group Securities's Amgen position peaked at $3.11M in Q3 2024.
  • 2,926 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.